Non-structural protein 7 (nsp7)

Non-structural protein 7 (nsp7) is a small, predominantly α-helical protein (83 amino acids) encoded by the SARS-CoV-2 orf1a gene[1]. It forms a heterodimer with nsp8, and together they bind nsp12, the core RNA-dependent RNA polymerase (RdRp), stabilizing the polymerase structure and improving its activity[1][2][3][6][7]. The nsp7:nsp8 interface is primarily hydrophobic, supporting complex formation that underpins efficient viral RNA replication and transcription. nsp7 is highly conserved across coronaviruses, and its disruption halts viral RNA synthesis, making it an attractive potential target for antiviral drug development. Complex structural dynamics allow nsp7:nsp8 to act as a processivity factor for the RdRp machinery[2][3][6]. - nsp7 and nsp8 together function as cofactors, and in the polymerase complex their inhibition would block replication of the viral RNA genome, directly impacting SARS-CoV-2 replication and pathogenicity[1][6]. - The precise structure, assembly, and interfaces of nsp7–nsp8–nsp12 have been resolved in multiple crystal and cryo-EM structures, facilitating rational drug discovery approaches[1][2][3][6][7].

Other names

nsp7Non-structural protein 7SARS-CoV-2 nsp7

For drugs or small molecules designed to interact with nsp7 (none approved yet), typical mechanisms would include: - Inhibition of nsp7-nsp8/nsp12 interactions, disrupting formation of the functional polymerase complex and inhibiting viral RNA replication[1][2][3][6].